ArticleCancers2023

Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect.

Brett A Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.